Mergers & Acquisitions Mergers & Acquisitions

Virtus Health's Adora Fertility deal to face March trial in Australian antitrust lawsuit

By Laurel Henning
  • 10 Nov 2021 18:25
  • 10 Nov 2021 18:25
Australian reproductive technology company Virtus Health will see its plans to buy up industry peer, Helius-owned Adora Fertility, face court hearings in March 2022.
In an online administrative hearing today, Federal Court of Australia Judge Jonathan Beach set aside two weeks for hearings in the ongoing competition-law dispute brought against

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Laurel Henning

Senior Correspondent

Laurel is a senior correspondent specializing in competition law, data privacy and security, in Australia and New Zealand. Laurel reports from Sydney on criminal-cartel legislation and white-collar crime, as well as competition and consumer lawsuits involving companies including Google, Meta Platforms and Apple. While at MLex Laurel has also reported boardroom disputes and shareholder campaigns agitating for changes to company strategy. Laurel joined MLex in 2013 and reported for five years on European energy and climate policies from Brussels. In that time, Laurel covered the regulation of emissions and technological developments pertaining to the energy sector within the EU, as well as the Paris agreement in 2015. A graduate of the University of Liverpool, Laurel studied English and French before beginning a career in journalism with MLex.

Discover MLex

Stay on top of global regulatory developments

Latest News